Gilead Wins FDA Approval for Bixlenvo HIV Single Tablet
FOSTER CITY, Calif. – August 27, 2026 Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA)...
FDA IND Clearance
Advertisement
Adicet Bio Gains FDA Clearance for ADI-212 IND in mCRPC
REDWOOD CITY, Calif. – August 27, 2026 Adicet Bio, Inc. announced that the U.S. Food and Drug Administration (FDA)...
Kedrion Extends U.S. Agreement to Support GAMMAKED Access
FORT LEE, N.J., August 18, 2026 Kedrion Biopharma announced an extension of its U.S. agreement with Grifols to continue...
Amygdala Advances ANS-858 After FDA IND Clearance
PALO ALTO, Calif., August 18, 2026 Amygdala Neurosciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has...
Graviton Bioscience Gains FDA IND Clearance for GV101
New York, New York, August,11, 2026 Graviton Bioscience Corporation, a clinical-stage biotechnology company developing selective ROCK2 inhibitors, has announced...
Advertisements
Ascletis Begins U.S. Phase I Trials of Monthly Obesity Drugs
Hong Kong, China, August 10, 2026 Ascletis Pharma Inc. has announced the initiation of two Phase I clinical studies...
Ractigen’s RAG-1C Wins FDA IND Clearance for PVR
NANTONG, China, July 31, 2026 Ractigen Therapeutics has received U.S. Food and Drug Administration (FDA) clearance of its Investigational...
Iksuda Therapeutics Secures FDA IND Clearance for IKS04
Newcastle, UK, July 30, 2026 Iksuda Therapeutics has received U.S. Food and Drug Administration (FDA) Investigational New Drug (IND)...
CoRegen Wins FDA IND Clearance for CRG-150
HOUSTON, July 7, 2026 CoRegen, Inc. has received U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) clearance...
Merck’s KEYTRUDA Tops Chemo in dMMR Endometrial Cancer
RAHWAY, N.J., July 15, 2026 Merck has announced that its blockbuster PD-1 inhibitor KEYTRUDA® (pembrolizumab) achieved the primary endpoint...
Advertisement
